Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update

~ Achieved Second Quarter 2025 Total Net Revenues of $9.7 Million ~

~ Double Digit New Accounts in the Second Quarter of 2025, Including Notable Quarter-Over-Quarter Growth in Both Large Community Practices and Academic Centers, Supported by Targeted Sales Strategy and Enhanced Patient Support Services for PEDMARK^® ~

Read more at globenewswire.com